AR

Afreen Riyaz

Active Director Designated Partner DIN 10924232
DIN 10924232 First appointment Jan 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Jan 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Afreen Riyaz

Data last updated:

Afreen Riyaz is a Designated Partner at Medvon Healthcare Llp (since 2026) and Designated Partner at Zyrix Pharma Llp (since 2025).

DIN 10924232
Primary Designation Designated Partner
First Appointment 27 Jan 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner18 Sep 20262026Active
Zyrix Pharma Llp ACL-5895
Designated Partner27 Jan 20252025Active

Board colleagues of Afreen Riyaz

NameDINCompanyDesignation
Shamsher Zuber Shaikh11954326Medvon Healthcare LlpDesignated Partner
Mohd Kaif Khan10924233Zyrix Pharma LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Zyrix Pharma Llp
Medvon Healthcare Llp
Premium access

Shareholding and investment profile for Afreen Riyaz

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Afreen Riyaz

Afreen Riyaz currently holds 2 directorships: Medvon Healthcare Llp (Designated Partner, since 18 Sep 2026); Zyrix Pharma Llp (Designated Partner, since 27 Jan 2025).

Afreen Riyaz was first appointed on 27 Jan 2025 as Designated Partner at Zyrix Pharma Llp. The most recent appointment on record is 18 Sep 2026 at Medvon Healthcare Llp.

The current boards of Afreen Riyaz's companies include Shamsher Zuber Shaikh (Medvon Healthcare Llp), Mohd Kaif Khan (Zyrix Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available